Edaravone Exerts Protective Effects on Mice Intestinal Injury without Interfering with the Anti-Tumor Effects of Radiation

The appropriate dosage of edaravone—a radioprotective agent—and its effect on tumors are unknown. This study evaluated the effects of edaravone on intestinal injuries and tumors in mice induced by whole body X-ray irradiation. Small intestinal mucositis was induced in C3H/HeNSlc mice using a single...

Full description

Bibliographic Details
Main Authors: Terufumi Kawamoto, Keisuke Sasai
Format: Article
Language:English
Published: MDPI AG 2023-06-01
Series:Current Issues in Molecular Biology
Subjects:
Online Access:https://www.mdpi.com/1467-3045/45/7/340
_version_ 1827733473875460096
author Terufumi Kawamoto
Keisuke Sasai
author_facet Terufumi Kawamoto
Keisuke Sasai
author_sort Terufumi Kawamoto
collection DOAJ
description The appropriate dosage of edaravone—a radioprotective agent—and its effect on tumors are unknown. This study evaluated the effects of edaravone on intestinal injuries and tumors in mice induced by whole body X-ray irradiation. Small intestinal mucositis was induced in C3H/HeNSlc mice using a single X-ray dose (15 Gy). Edaravone (15, 30, and 100 mg/kg) was administered 30 min before irradiation to evaluate its protective effect. After 3.5 days, the jejunum was removed and the histological changes were evaluated. Next, C3H/HeNSlc mice with squamous cell carcinoma VII tumors were provided the same single X-ray dose and 100 mg/kg edaravone; further, the tumors were immediately induced after irradiation. The tumor cell viability was detected using an in vivo–in vitro colony formation assay. We found that the intestinal colony-forming ability after irradiation was significantly higher in the 100 mg/kg edaravone group than that in the control group. Moreover, the apoptotic cells in the villi immunohistochemically stained with cleaved caspase-3 were significantly lower in the 100 mg/kg edaravone group than in the control group. We found no radioprotective effects of intraperitoneally inoculated edaravone in both hind legs on squamous cell carcinoma VII tumors. These findings suggest that 100 mg/kg edaravone exerts protective effects on small intestinal injuries without interfering with the antitumor effects of radiation.
first_indexed 2024-03-11T01:11:49Z
format Article
id doaj.art-90b1c6cb8d464d59995c62972a23cbde
institution Directory Open Access Journal
issn 1467-3037
1467-3045
language English
last_indexed 2024-03-11T01:11:49Z
publishDate 2023-06-01
publisher MDPI AG
record_format Article
series Current Issues in Molecular Biology
spelling doaj.art-90b1c6cb8d464d59995c62972a23cbde2023-11-18T18:50:51ZengMDPI AGCurrent Issues in Molecular Biology1467-30371467-30452023-06-014575362537210.3390/cimb45070340Edaravone Exerts Protective Effects on Mice Intestinal Injury without Interfering with the Anti-Tumor Effects of RadiationTerufumi Kawamoto0Keisuke Sasai1Department of Radiation Oncology, Graduate School of Medicine, Juntendo University, Tokyo 113-8421, JapanDepartment of Radiation Oncology, Graduate School of Medicine, Juntendo University, Tokyo 113-8421, JapanThe appropriate dosage of edaravone—a radioprotective agent—and its effect on tumors are unknown. This study evaluated the effects of edaravone on intestinal injuries and tumors in mice induced by whole body X-ray irradiation. Small intestinal mucositis was induced in C3H/HeNSlc mice using a single X-ray dose (15 Gy). Edaravone (15, 30, and 100 mg/kg) was administered 30 min before irradiation to evaluate its protective effect. After 3.5 days, the jejunum was removed and the histological changes were evaluated. Next, C3H/HeNSlc mice with squamous cell carcinoma VII tumors were provided the same single X-ray dose and 100 mg/kg edaravone; further, the tumors were immediately induced after irradiation. The tumor cell viability was detected using an in vivo–in vitro colony formation assay. We found that the intestinal colony-forming ability after irradiation was significantly higher in the 100 mg/kg edaravone group than that in the control group. Moreover, the apoptotic cells in the villi immunohistochemically stained with cleaved caspase-3 were significantly lower in the 100 mg/kg edaravone group than in the control group. We found no radioprotective effects of intraperitoneally inoculated edaravone in both hind legs on squamous cell carcinoma VII tumors. These findings suggest that 100 mg/kg edaravone exerts protective effects on small intestinal injuries without interfering with the antitumor effects of radiation.https://www.mdpi.com/1467-3045/45/7/340enteritisradiationradioprotectorradiotherapy
spellingShingle Terufumi Kawamoto
Keisuke Sasai
Edaravone Exerts Protective Effects on Mice Intestinal Injury without Interfering with the Anti-Tumor Effects of Radiation
Current Issues in Molecular Biology
enteritis
radiation
radioprotector
radiotherapy
title Edaravone Exerts Protective Effects on Mice Intestinal Injury without Interfering with the Anti-Tumor Effects of Radiation
title_full Edaravone Exerts Protective Effects on Mice Intestinal Injury without Interfering with the Anti-Tumor Effects of Radiation
title_fullStr Edaravone Exerts Protective Effects on Mice Intestinal Injury without Interfering with the Anti-Tumor Effects of Radiation
title_full_unstemmed Edaravone Exerts Protective Effects on Mice Intestinal Injury without Interfering with the Anti-Tumor Effects of Radiation
title_short Edaravone Exerts Protective Effects on Mice Intestinal Injury without Interfering with the Anti-Tumor Effects of Radiation
title_sort edaravone exerts protective effects on mice intestinal injury without interfering with the anti tumor effects of radiation
topic enteritis
radiation
radioprotector
radiotherapy
url https://www.mdpi.com/1467-3045/45/7/340
work_keys_str_mv AT terufumikawamoto edaravoneexertsprotectiveeffectsonmiceintestinalinjurywithoutinterferingwiththeantitumoreffectsofradiation
AT keisukesasai edaravoneexertsprotectiveeffectsonmiceintestinalinjurywithoutinterferingwiththeantitumoreffectsofradiation